Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection.

Elliott JC, Critchley L, Feaster DJ, Hasin DS, Mandler RN, Osorio G, Rodriguez AE, Del Rio C, Metsch LR.

Drug Alcohol Depend. 2019 Jun 5;201:171-177. doi: 10.1016/j.drugalcdep.2019.03.024. [Epub ahead of print]

PMID:
31234013
2.

Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis.

Shiu-Yee K, Brincks AM, Feaster DJ, Frimpong JA, Nijhawan A, Mandler RN, Schwartz R, Del Rio C, Metsch LR.

AIDS Behav. 2018 Sep;22(9):2757-2765. doi: 10.1007/s10461-017-2024-y.

PMID:
29305761
3.

Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.

Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D; CTN-0055 CHOICES Investigators.

Addiction. 2017 Jun;112(6):1036-1044. doi: 10.1111/add.13753. Epub 2017 Feb 8.

4.

Substance use and STI acquisition: Secondary analysis from the AWARE study.

Feaster DJ, Parish CL, Gooden L, Matheson T, Castellon PC, Duan R, Pan Y, Haynes LF, Schackman BR, Malotte CK, Mandler RN, Colfax GN, Metsch LR.

Drug Alcohol Depend. 2016 Dec 1;169:171-179. doi: 10.1016/j.drugalcdep.2016.10.027. Epub 2016 Oct 27.

5.

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C.

JAMA. 2016 Jul 12;316(2):156-70. doi: 10.1001/jama.2016.8914.

6.

Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.

Gooden L, Metsch LR, Pereyra MR, Malotte CK, Haynes LF, Douaihy A, Chally J, Mandler RN, Feaster DJ.

AIDS Behav. 2016 Sep;20(9):1893-906. doi: 10.1007/s10461-016-1300-6.

7.

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.

Bogenschutz MP, Donovan DM, Mandler RN, Perl HI, Forcehimes AA, Crandall C, Lindblad R, Oden NL, Sharma G, Metsch L, Lyons MS, McCormack R, Macias-Konstantopoulos W, Douaihy A.

JAMA Intern Med. 2014 Nov;174(11):1736-45. doi: 10.1001/jamainternmed.2014.4052. Erratum in: JAMA Intern Med. 2015 Mar;175(3):470. Macias Konstantopoulos, Wendy [Corrected to Macias-Konstantopoulos, Wendy].

8.

Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing.

Kyle TL, Horigian VE, Tross S, Gruber VA, Pereyra M, Mandler RN, Feaster DJ, Metsch LR.

AIDS Behav. 2015 Mar;19(3):536-42. doi: 10.1007/s10461-014-0864-2.

9.

Identifying patients with problematic drug use in the emergency department: results of a multisite study.

Macias Konstantopoulos WL, Dreifuss JA, McDermott KA, Parry BA, Howell ML, Mandler RN, Fitzmaurice GM, Bogenschutz MP, Weiss RD.

Ann Emerg Med. 2014 Nov;64(5):516-25. doi: 10.1016/j.annemergmed.2014.05.012. Epub 2014 Jul 3.

10.

Alcohol, tobacco, and drug use among emergency department patients.

Sanjuan PM, Rice SL, Witkiewitz K, Mandler RN, Crandall C, Bogenschutz MP.

Drug Alcohol Depend. 2014 May 1;138:32-8. doi: 10.1016/j.drugalcdep.2014.01.025. Epub 2014 Feb 12.

11.

Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.

Metsch LR, Feaster DJ, Gooden L, Schackman BR, Matheson T, Das M, Golden MR, Huffaker S, Haynes LF, Tross S, Malotte CK, Douaihy A, Korthuis PT, Duffus WA, Henn S, Bolan R, Philip SS, Castro JG, Castellon PC, McLaughlin G, Mandler RN, Branson B, Colfax GN.

JAMA. 2013 Oct 23;310(16):1701-10. doi: 10.1001/jama.2013.280034.

12.

Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN.

Am J Public Health. 2012 Jun;102(6):1160-7. doi: 10.2105/AJPH.2011.300460. Epub 2012 Apr 19.

13.

Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness.

Korthuis PT, Feaster DJ, Gomez ZL, Das M, Tross S, Wiest K, Douaihy A, Mandler RN, Sorensen JL, Colfax G, McCarty D, Cohen SE, Penn PE, Lape D, Metsch LR.

Addict Behav. 2012 Apr;37(4):552-5. doi: 10.1016/j.addbeh.2011.12.001. Epub 2011 Dec 14.

14.

Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED).

Bogenschutz MP, Donovan DM, Adinoff B, Crandall C, Forcehimes AA, Lindblad R, Mandler RN, Oden NL, Perl HI, Walker R.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):417-25. doi: 10.3109/00952990.2011.596971.

15.

NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.

Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM; Clinical Trials Network HIV Special Interest Group.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):283-93. doi: 10.3109/00952990.2011.596977.

16.

Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.

Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gómez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF.

Neurology. 2011 Apr 5;76(14):1229-37. doi: 10.1212/WNL.0b013e318214332c. Epub 2011 Mar 2.

17.

Absence of cortical demyelination in neuromyelitis optica.

Popescu BF, Parisi JE, Cabrera-Gómez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF.

Neurology. 2010 Dec 7;75(23):2103-9. doi: 10.1212/WNL.0b013e318200d80c.

18.

Reducing HIV-related risk behaviors among injection drug users in residential detoxification.

Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson CJ, Choi D, Robinson J, Calsyn DA, Mandler RN, Jenkins LM, Thompson LL, Dempsey CL, Liepman MR, McCarty D.

AIDS Behav. 2011 Jan;15(1):30-44. doi: 10.1007/s10461-010-9751-7.

19.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

PMID:
17282996
20.

Neuromyelitis optica - Devic's syndrome, update.

Mandler RN.

Autoimmun Rev. 2006 Oct;5(8):537-43. Epub 2006 Mar 21. Review.

PMID:
17027889
21.

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.

Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A; Psuedobulbar Affect in Multiple Sclerosis Study Group.

Ann Neurol. 2006 May;59(5):780-7.

PMID:
16634036
22.

Nerve conduction studies of the lateral femoral cutaneous nerve. Implications in the diagnosis of meralgia paresthetica.

Russo MJ, Firestone LB, Mandler RN, Kelly JJ Jr.

Am J Electroneurodiagnostic Technol. 2005 Sep;45(3):180-5.

PMID:
16201160
23.

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J; Northeast ALS Consortium.

Neurology. 2003 Aug 26;61(4):456-64.

PMID:
12939417
24.
25.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H.

Brain. 2002 Jul;125(Pt 7):1450-61.

26.

The ALS Patient Care Database: insights into end-of-life care in ALS.

Mandler RN, Anderson FA Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M; ALS C.A.R.E. Study Group.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Dec;2(4):203-8.

PMID:
11958732
27.
28.
29.

Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelectrode findings.

Maselli RA, Agius M, Lee EK, Bakshi N, Mandler RN, Ellis W.

Ann N Y Acad Sci. 1998 May 13;841:497-500. No abstract available.

PMID:
9668281
30.

Fulminant demyelinating neuropathy mimicking cerebral death.

Bakshi N, Maselli RA, Gospe SM Jr, Ellis WG, McDonald C, Mandler RN.

Muscle Nerve. 1997 Dec;20(12):1595-7.

PMID:
9390675
31.

Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study.

Maselli RA, Ellis W, Mandler RN, Sheikh F, Senton G, Knox S, Salari-Namin H, Agius M, Wollmann RL, Richman DP.

Muscle Nerve. 1997 Oct;20(10):1284-95.

PMID:
9324085
32.

Myeloneuropathy in POEMS syndrome.

Mandler RN, King MK.

Muscle Nerve. 1996 Dec;19(12):1614-6. No abstract available.

PMID:
8941279
33.

Stimulated single-fiber electromyography in wound botulism.

Mandler RN, Maselli RA.

Muscle Nerve. 1996 Sep;19(9):1171-3. No abstract available.

PMID:
8761277
34.

Quantitative measurement of muscle strength in the mouse.

Smith JP, Hicks PS, Ortiz LR, Martinez MJ, Mandler RN.

J Neurosci Methods. 1995 Nov;62(1-2):15-9.

PMID:
8750080
35.

Neurologic manifestations of intravascular lymphomatosis.

Chapin JE, Davis LE, Kornfeld M, Mandler RN.

Acta Neurol Scand. 1995 Jun;91(6):494-9.

PMID:
7572046
36.

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Mandler RN, Davis LE, Jeffery DR, Kornfeld M.

Ann Neurol. 1993 Aug;34(2):162-8.

PMID:
8338340
38.

Progesterone but not estrogen depolarizes natural killer cells.

Mandler RN, Seamer LC, Domalewski MD, Bankhurst AD.

Nat Immun. 1993 May-Jun;12(3):128-35.

PMID:
8392407
39.

Castleman's disease in POEMS syndrome with elevated interleukin-6.

Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M.

Cancer. 1992 Jun 1;69(11):2697-703.

PMID:
1571900
40.

Muscle lactate dehydrogenase activity is decreased in murine motor neuron disease.

Mandler RN, Baca JM.

Brain Res. 1992 Apr 3;576(2):337-8.

PMID:
1515928
42.

Neoplastic angioendotheliomatosis.

Raroque HG Jr, Mandler RN, Griffey MS, Orrison WW, Kornfeld M.

Arch Neurol. 1990 Aug;47(8):929-30.

PMID:
2375700
43.

Electrical and chemical excitability appear one week before birth in the embryonic rat spinal cord.

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Smith SV, Barker JL.

Brain Res. 1990 Jul 2;522(1):46-54.

PMID:
1699635
44.

Human natural killer cells express Na+ channels. A pharmacologic flow cytometric study.

Mandler RN, Seamer LC, Whitlinger D, Lennon M, Rosenberg E, Bankhurst AD.

J Immunol. 1990 Mar 15;144(6):2365-70.

PMID:
2155964
45.

Flow cytometric analysis of membrane potential in embryonic rat spinal cord cells.

Mandler RN, Schaffner AE, Novotny EA, Lange GD, Barker JL.

J Neurosci Methods. 1988 Jan;22(3):203-13.

PMID:
3361946
46.

beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.

Mandler RN, Biddison WE, Mandler R, Serrate SA.

J Immunol. 1986 Feb 1;136(3):934-9.

PMID:
2934481

Supplemental Content

Loading ...
Support Center